|
|
|
|
||
Re: FORWARD II ASCO AbstractCorrect me if I am wrong but the data in this abstract for the subset analysis of pts (n = 16) who were bevacizumab-naïve, had 1-2 prior therapies is identical to the data present in May2018. http://investor.immunogen.com/static-files/6f3c4aa2-bee7-47ce-908b-9e1f8a82e48d Are these different patients? Strange to have the same exact outcome. Sooner |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
49458 | Re: FORWARD II ASCO Abstract | Bibliobiftek | 2 | 5/15/2019 8:53:10 PM |